Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
Abstract In clinical settings, cancer vaccines as monotherapies have displayed limited success compared to other cancer immunotherapeutic treatments. Nanoscale formulations have the ability to increase